Direkt zum Inhalt

Antipsychotic medication for challenging behaviour in people with learning disability

The term 'challenging behaviour', in the absence of psychiatric disorder, encompasses a wide range of behaviours that may be harmful to people or property, may be difficult to manage and may limit access to community facilities. Antipsychotic medications have been used to modify such behaviours in people with learning disability, but there is no randomised controlled trial-based information that suggests antipsychotic medication is either helpful or harmful for adults with learning disability and challenging behaviour.

Hintergrund

The term 'challenging behaviour', in the absence of psychiatric disorder, encompasses a wide range of behaviours that may be harmful to people or property, may be difficult to manage and may limit access to community facilities. Antipsychotic medications have been used to modify such behaviours in people with learning disability, but there is little evidence to suggest that the benefits outweigh the risks.

Zielsetzungen

To determine the effectiveness of antipsychotic medication for people with learning disability and challenging behaviour without additional mental illness.

Suchstrategie

Biological Abstracts, the Cochrane Library, EMBASE, MEDLINE, PsycINFO and BIOSIS were searched. Further references were sought from published trials and pharmaceutical companies. Trials were reliably identified and data extracted.

Auswahlkriterien

All randomised controlled trials of antipsychotic medication versus placebo.

Datensammlung und ‐analyse

Reviewers independently evaluated and analysed data on an intention to treat basis. Data were evaluated at 4, 8 and 12 weeks as longer follow-up data were not available. Reviewers assumed that those subjects lost to follow-up had a bad outcome.

Hauptergebnisse

Only nine randomised controlled trials could be included in the analyses. These provided no evidence of whether antipsychotic medication helps or harms adults with learning disability and challenging behaviour.

Schlussfolgerungen der Autoren

There are limited data on this important issue and more research is urgently needed.

Zitierung
Brylewski J, Duggan L. Antipsychotic medication for challenging behaviour in people with learning disability. Cochrane Database of Systematic Reviews 2004, Issue 3. Art. No.: CD000377. DOI: 10.1002/14651858.CD000377.pub2.

So verwenden wir Cookies

Wir verwenden notwendige Cookies, damit unsere Webseite funktioniert. Wir möchten auch optionale Cookies für Google Analytics setzen, um unsere Webseite zu verbessern. Solche optionalen Cookies setzen wir nur, wenn Sie dies zulassen. Wenn Sie dieses Programm aufrufen, wird ein Cookie auf Ihrem Gerät platziert, um Ihre Präferenzen zu speichern. Sie können Ihre Cookie-Einstellungen jederzeit ändern, indem Sie auf den Link "Cookie-Einstellungen" am Ende jeder Seite klicken.
Auf unserer Seite zu Cookies finden Sie weitere Informationen, wie diese Cookies funktionieren die Seite mit den Cookies.

Alle akzeptieren
Anpassen